Long-term follow-up after adrenalectomy for primary aldosteronism

被引:90
作者
Meyer, A
Brabant, G
Behrend, M
机构
[1] Hannover Med Sch, Viszeral & Transplantat Chirurg Klin, D-30625 Hannover, Germany
[2] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30625 Hannover, Germany
关键词
D O I
10.1007/s00268-004-7496-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
The objective of this study was to assess the long-term effects of adrenalectomy on the blood pressure and antihypertensive medication in patients with primary aldosteronism (PA). Twenty-four patients (15 female and 9 male) with a mean age of 48.3 +/- 10.8 years underwent surgery for PA in our institution between 1988 and 2001. All subjects were reexamined with a complete clinical work-up after a mean follow-up period of 86 48 months, including blood pressure readings (< 140/90 mmHg defined as normal), endocrine adrenal function, and specific medication. All patients suffered from hypertension (onset 8.5 +/- 5.5 years prior to surgery). In 92% of the patients, hypokalemia was present (onset 2.0 +/- 2.6 years prior to surgery). The histopathologic examinations revealed unilateral adenomas in 23 patients and a bilateral hyperplasia in one patient. At follow-up, 33% (8) of the patients were completely cured (normal blood pressure and no antihypertensive treatment), with seven of these eight patients being under 50 years of age at the time of surgery. One patient revealed a contralateral aldosterone-secreting adrenal adenoma during the subsequent endocrine and imaging examination 44 months after the first operation. Despite normalized plasma-aldosterone concentration (PAC), plasma-renin-activity (PRA) and serum potassium levels, a long-lasting insufficiently treated hypertension due to the delayed diagnosis in patients with PA may explain the persistent blood pressure elevation, indicating the necessity of a life-long, regular control of the blood pressure and antihypertensive medication.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 36 条
[1]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[2]   DIAGNOSIS AND TREATMENT OF PRIMARY HYPERALDOSTERONISM [J].
BLUMENFELD, JD ;
SEALEY, JE ;
SCHLUSSEL, Y ;
VAUGHAN, ED ;
SOS, TA ;
ATLAS, SA ;
MULLER, FB ;
ACEVEDO, R ;
ULICK, S ;
LARAGH, JH .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (11) :877-885
[3]   Diagnosis and treatment of primary aldosteronism [J].
Blumenfeld, JD ;
Vaughan, ED .
WORLD JOURNAL OF UROLOGY, 1999, 17 (01) :15-21
[4]   Hyperaldosteronism among with resistant black and white subjects hypertension [J].
Calhoun, DA ;
Nishizaka, MK ;
Zaman, MA ;
Thakkar, RB ;
Weissmann, P .
HYPERTENSION, 2002, 40 (06) :892-896
[5]  
Celen O, 1996, ARCH SURG-CHICAGO, V131, P646
[6]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[7]  
CONN JW, 1955, J LAB CLIN MED, V45, P3
[8]   Primary hyperaldosteronism in essential hypertensives:: Prevalence, biochemical profile, and molecular biology [J].
Fardella, CE ;
Mosso, L ;
Gómez-Sánchez, C ;
Cortés, P ;
Soto, J ;
Gómez, L ;
Pinto, M ;
Huete, A ;
Oestreicher, E ;
Foradori, A ;
Montero, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1863-1867
[9]   ADRENALECTOMY IN PRIMARY ALDOSTERONISM - A LONG-TERM FOLLOW-UP-STUDY IN 52 PATIENTS [J].
FAVIA, G ;
LUMACHI, F ;
SCARPA, V ;
DAMICO, DF .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :680-684
[10]   Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy [J].
Fukudome, Y ;
Fujii, K ;
Arima, H ;
Ohya, Y ;
Tsuchihashi, T ;
Abe, I ;
Fujishima, M .
HYPERTENSION RESEARCH, 2002, 25 (01) :11-18